ArticleBMC infectious diseases2025
Detection of HBV and HCV Seroprevalence using rapid point-of-care tests among earthquake survivors in Southeastern Türkiye.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTürkiye has a moderate seroprevalence of HBV infection in its general population, with the Southeastern Anatolia Region exhibiting the highest rate. In contrast, the seroprevalence of HCV infection in Türkiye is low. The study aimed to determine the prevalence of HBV and HCV in the communities affected by the earthquake in Southeastern Türkiye.
methodsThis was a cross-sectional study in Southeastern Türkiye in December 2023, eleven months after the 2023 Türkiye-Syria earthquakes. HBsAg and anti-HCV were investigated using rapid screening tests on blood samples from participants selected from 251 containers, where 1,213 people resided.
resultsOut of 251 samples tested, 13 (5.2%) were positive for HBV, while none (0.0%) tested positive for HCV. When comparing the risk factors for HBV infection between the positive and negative groups, earthquake survivors who tested positive for HBsAg were significantly more likely to be male sex (p = 0.018) and to have a family history of HBV (p < 0.001). There were no significant differences (p > 0.05) in age, number of household members, education level, marital status, history of surgery or dental procedure, tattoo-piercing, and history of blood transfusion.
conclusionsIn Southeastern Türkiye, 5.2% of earthquake survivors tested positive for HBsAg using rapid point-of-care tests. More comprehensive studies are needed to determine the prevalence of HBsAg and anti-HCV in the general population and to identify risk factors. CLINICAL TRIAL: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.